Thyroxine | Serum or Plasma | Chemistry - challenge   LP387146-6

LOINC Hierarchy


Select the title to see children of the section (▸) or the LOINC code. Select a code to view information about the section/code.

Thyroxine (T4) [Mass/volume] in Serum or Plasma --1 hours post dose levothyroxine   90796-4

Thyroxine (T4) [Mass/volume] in Serum or Plasma --1 hour post XXX challenge   12931-2

Thyroxine (T4) [Mass/volume] in Serum or Plasma --2 hours post dose levothyroxine   90797-2

Thyroxine (T4) [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge   12923-9

Thyroxine (T4) [Mass/volume] in Serum or Plasma --3 hours post dose levothyroxine   90798-0

Thyroxine (T4) [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge   12924-7

Thyroxine (T4) [Mass/volume] in Serum or Plasma --4 hours post dose levothyroxine   90799-8

Thyroxine (T4) [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge   12925-4

Thyroxine (T4) [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge   12926-2

Thyroxine (T4) [Mass/volume] in Serum or Plasma --6 hours post dose levothyroxine   90800-4

Thyroxine (T4) [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge   12927-0

Thyroxine (T4) [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge   12928-8

Thyroxine (T4) [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge   12929-6

Thyroxine (T4) [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge   12930-4

Thyroxine (T4) [Mass/volume] in Serum or Plasma --baseline   27891-1


Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © 1995-2024, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://loinc.org/license for the full LOINC copyright and license.

demo
request yours today
subscribe
start today
newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.